Hisamitsu Pharmaceutical Financials

Hisamitsu Pharmaceutical Stock Summary

Hisamitsu Pharmaceutical competes with Merck, Takeda Pharmaceutical, HANSOH PHARMAC, Guangzhou Baiyunshan, and Elanco Animal. Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals in Japan. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. HISAMITSU PHARMA operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2770 people.

Hisamitsu Pharmaceutical Key Financial Ratios

There are many critical financial ratios that Hisamitsu Pharmaceutical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Hisamitsu Pharmaceutical reports annually and quarterly.

Hisamitsu Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Hisamitsu Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Hisamitsu Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hisamitsu Pharmaceutical competition to find correlations between indicators driving Hisamitsu Pharmaceutical's intrinsic value. More Info.Hisamitsu Pharmaceutical Co is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about  0.42  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Hisamitsu Pharmaceutical Co is roughly  2.38 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hisamitsu Pharmaceutical's earnings, one of the primary drivers of an investment's value.

Hisamitsu Pharmaceutical Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Hisamitsu Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Hisamitsu Pharmaceutical Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Hisamitsu Pharmaceutical Co based on widely used predictive technical indicators. In general, we focus on analyzing Hisamitsu Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Hisamitsu Pharmaceutical's daily price indicators and compare them against related drivers.

When running Hisamitsu Pharmaceutical's price analysis, check to measure Hisamitsu Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hisamitsu Pharmaceutical is operating at the current time. Most of Hisamitsu Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Hisamitsu Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hisamitsu Pharmaceutical's price. Additionally, you may evaluate how the addition of Hisamitsu Pharmaceutical to your portfolios can decrease your overall portfolio volatility.